InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Wagenheim Philip, Director. Director active across 2 companies, notably Immunome Inc.. Aggregated, 4 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €853k. History available since 24 May 2021. The latest transaction was filed on 20 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Philip Wagenheim is a Director at Immunome Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Immunome.